How much debt does Trinity Biotech have?

Trinity Biotech had total debt of $137.98M as of Mar 31, 2026, against $5.14M in cash and short-term investments. Total debt was $100.76M a year earlier.

What are Trinity Biotech's total assets?

Trinity Biotech reported total assets of $105.17M as of Mar 31, 2026, up 1.8% from $103.29M a year earlier. Total liabilities were $177.15M.

What is Trinity Biotech's shareholders' equity?

Trinity Biotech's shareholders' equity was negative at −$71.98M as of Mar 31, 2026, so its liabilities exceeded its assets.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry.

Trinity Biotech (TRIB) Balance Sheet: Assets & Liabilities

Trinity Biotech Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Trinity Biotech plc (TRIB) - Annual data in millions USD
Breakdown	FY 2025	FY 2025	FY 2024	FY 2024	FY 2023	FY 2023	FY 2022	FY 2021	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Mar 2026	Dec 2025	Mar 2025	Dec 2024	Mar 2024	Dec 2023	Dec 2022	Mar 2022	Dec 2021	Dec 2020	Mar 2020	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	5.14	5.14	5.17	5.17	3.69	3.69	6.58	25.91	25.91	27.33	16.40	30.28	57.61
Cash & Short-Term Investments	5.14	5.14	5.17	5.17	3.69	3.69	6.58	25.91	25.91	27.33	16.40	30.28	57.61
Accounts Receivable	10.28	9.36	14.60	13.42	13.38	13.90	12.62	15.71	16.12	24.60	22.39	25.22	21.29
Inventory	18.83	18.83	19.37	19.37	19.93	19.93	22.50	29.12	29.12	30.22	32.02	30.36	32.81
Other Current Assets	1.65	0.46	1.98	0.52	2.04	1.52	0.00	1.95	1.95	1.16	0.58	0.81	0.89
Total Current Assets	35.90	35.90	41.12	41.12	39.04	39.04	46.67	72.69	72.69	83.30	71.39	86.66	112.59
Non-Current Assets
Property, Plant & Equipment (Net)	5.30	5.30	4.62	4.62	1.89	1.89	5.68	5.92	5.92	8.55	9.29	5.36	5.80
Long-Term Investments	3.02	2.77	2.46	2.46	0.21	-	0.21	0.15	-	0.44	0.40	0.48	1.05
Goodwill	13.97	13.97	13.84	13.84	0.00	16.27	12.54	12.54	35.98	12.59	12.59	16.14	17.90
Intangible Assets	43.02	43.02	37.50	37.50	16.27	1.17	22.73	23.44	5.77	21.27	31.06	36.81	46.86
Other Non-Current Assets	0.03	0.03	0.19	0.03	0.04	2.23	0.06	0.06	4.31	0.06	0.08	0.08	-0.27
Total Non-Current Assets	69.26	69.26	62.17	62.17	20.39	20.39	45.44	46.21	46.21	47.10	59.68	64.57	80.02
Total Assets	105.17	105.17	103.29	103.29	59.44	59.44	92.10	118.90	118.90	130.40	131.07	151.24	192.62
Current Liabilities
Accounts Payable	11.48	11.48	6.83	6.83	3.89	12.80	6.21	6.76	15.13	7.10	7.83	8.12	8.05
Short-Term Debt	110.81	108.23	2.50	0.21	1.90	0.21	0.21	85.29	83.31	5.06	2.40	0.44	0.35
Current Portion of Long-Term Debt	-	108.02	-	0.21	-	0.21	0.21	-	83.31	-	-	-	-
Accrued Liabilities	-	16.93	-	13.60	-	8.07	8.59	-	8.12	9.69	-	-	-
Deferred Revenue	0.19	0.19	0.20	0.20	0.05	0.05	0.11	0.14	0.21	4.45	0.29	0.31	0.28
Other Current Liabilities	18.73	0.69	21.55	2.82	8.92	0.33	9.11	7.88	0.07	9.61	8.87	8.53	12.24
Total Current Liabilities	141.21	141.21	32.10	32.10	15.04	15.04	17.34	100.49	100.49	27.06	19.45	17.60	21.23
Non-Current Liabilities
Long-Term Debt	27.17	16.33	98.27	87.79	65.52	54.86	58.05	13.87	83.31	99.28	99.77	81.91	93.49
Deferred Tax Liabilities	4.67	4.67	4.56	4.56	2.30	2.30	5.06	4.86	4.86	4.91	7.14	7.43	10.83
Other Non-Current Liabilities	4.10	8.77	3.55	1.81	0.53	2.83	1.57	4.86	4.86	1.37	0.00	8.09	2.23
Total Non-Current Liabilities	35.94	35.94	106.38	106.38	68.35	68.35	76.94	18.72	18.72	105.56	106.91	89.58	106.19
Total Liabilities	177.15	177.15	138.47	138.47	83.38	83.38	94.28	119.21	119.21	132.62	126.36	107.18	127.42
Stockholders' Equity
Common Stock	0.04	0.04	4.19	4.19	1.97	1.97	1.96	1.21	1.21	1.21	1.22	1.22	1.22
Retained Earnings	-116.17	-116.17	-79.12	-79.12	-48.64	-48.64	-26.70	12.56	12.56	10.57	11.51	24.37	46.16
Accumulated Other Comprehensive Income	5.27	-1.44	-5.44	-5.44	1.03	-5.68	-5.69	-5.36	-5.36	-5.27	-24.21	2.28	1.63
Treasury Stock	-	24.92	-	24.92	-	24.92	24.92	-	24.92	-	-	-	-
Additional Paid-in Capital	38.88	63.80	45.18	63.40	21.70	46.62	46.46	-8.74	16.19	-8.74	-8.74	-8.74	-8.60
Shares Outstanding	-	374.21	-	359.19	-	153.31	152.43	-	83.61	-	-	-	-
Total Stockholders' Equity	-71.98	-71.98	-35.18	-35.18	-23.95	-23.95	-2.18	-0.32	-0.32	-2.22	4.71	44.05	65.20
Total Liabilities & Equity	105.17	105.17	103.29	103.29	59.44	59.44	92.10	118.90	118.90	130.40	131.07	151.24	192.62

Source: Company financial statements from annual and quarterly filings. Data as of Mar 31, 2026. Data sources and methodology

Trinity Biotech Balance Sheet Analysis

Frequently Asked Questions About Trinity Biotech Balance Sheet